A detailed history of Lmcg Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lmcg Investments, LLC holds 7,092 shares of BMY stock, worth $417,506. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,092
Previous 7,107 0.21%
Holding current value
$417,506
Previous $295,000 24.41%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$39.66 - $51.75 $594 - $776
-15 Reduced 0.21%
7,092 $367,000
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $2,495 - $3,285
-62 Reduced 0.86%
7,107 $295,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $32,242 - $36,556
-672 Reduced 8.57%
7,169 $388,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $5.73 Million - $6.84 Million
-118,251 Reduced 93.78%
7,841 $402,000
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $297,612 - $332,776
-5,141 Reduced 3.92%
126,092 $7.32 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $4.91 Million - $5.45 Million
77,040 Added 142.16%
131,233 $8.39 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $85,488 - $96,963
-1,301 Reduced 2.34%
54,193 $3.76 Million
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $111,485 - $132,014
-1,628 Reduced 2.85%
55,494 $3.99 Million
Q3 2022

Nov 07, 2022

SELL
$0.13 - $76.84 $177 - $104,886
-1,365 Reduced 2.33%
57,122 $4.06 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $51,995 - $57,265
-716 Reduced 1.21%
58,487 $4.5 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $3.64 Million - $4.36 Million
59,203 New
59,203 $4.32 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lmcg Investments, LLC Portfolio

Follow Lmcg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmcg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lmcg Investments, LLC with notifications on news.